News

Latest Releases

Klobuchar, Smith Secure Significant Federal Funding for Low Carbon Hydrogen Production

WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that the Heartland Hydrogen Hub, made up of public and private partners in Minnesota, North Dakota, and South Dakota, will receive significant federal funding from the U.S. Department of Energy to produce low carbon hydrogen for power generation, natural gas distribution systems, and agricultural use.  “This investment will be an important part of our energy future, unlocking innovation and new sources of energy that will benefit our whole state,” said Klobuchar. “The combined public/private investments will create good-paying jobs and power Minnesota for years to come.” “The clean energy transition is happening—the question is whether we lead or follow. I want us to lead,” said Smith. “This funding will jumpstart the production of hydrogen from clean energy resources in Minnesota to help decarbonize various sectors of the economy, while creating more than 1,500 good paying jobs in our state. I’m proud of our work to pass the Bipartisan Infrastructure Law, which made investments like these possible.”  The Heartland Hydrogen Hub was one of just seven proposed clean hydrogen hubs nationwide selected to receive funding through the Department of Energy’s Regional Clean Hydrogen Hubs program.  The Regional Clean Hydrogen Hubs program and this funding were made possible through the Bipartisan Infrastructure Law, which Klobuchar and Smith helped pass in 2021.  The Regional Clean Hydrogen Hubs program will create a national network of clean hydrogen producers, consumers, and connective infrastructure while supporting the production, storage, and delivery of clean hydrogen.

Klobuchar, Smith, Budd Introduce Bipartisan Legislation to Support Volunteer Drivers

WASHINGTON – U.S. Senators Amy Klobuchar (D-MN), Tina Smith (D-MN), and Tedd Budd (R-NC) introduced the bipartisan Volunteer Driver Tax Appreciation Act to support volunteer drivers. Each year, volunteer drivers provide millions of rides for seniors and other non-drivers through churches, community organizations, and nonprofits, giving them access to health care, meals, and other essential services. This legislation would lower the financial burden that those volunteer drivers face by increasing the charitable mileage tax deduction rate for drivers from $0.14 to $0.655 per mile.  “Volunteer drivers are vital to rural communities across our state, helping seniors, people with disabilities, veterans, and others access necessities like meals and health care,” said Klobuchar. “By increasing the charitable mileage tax deduction rate, this legislation will help reduce the financial burden on volunteer drivers and ensure they can continue to serve their communities.”  “Minnesota’s volunteer drivers are critical to communities across our state, helping provide access to food, medication, and transport to seniors, veterans, and people with disabilities,” said Smith. “This legislation would increase the charitable mileage tax reimbursement rate and lower the financial burden for these volunteers. By more fairly compensating them for their services, we can ensure volunteers are able to continue helping the people who rely on them.” “Volunteer drivers provide critical services to predominantly rural areas of our country. Seniors, veterans, and disabled citizens are able to access food and healthcare through the charitable work of others. Increasing the charitable mileage reimbursement rate will make it easier for volunteer drivers

Sens. Smith, Warren Raise Questions about Accuracy of Secretary Azar’s Testimony Blaming Pharmacy Benefit Managers for High Drug Prices

WASHINGTON, DC [08/17/18]—Today, U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) questioned Health and Human Services (HHS) Secretary Alex Azar about his potentially misleading statements during his Senate testimony in which he blamed pharmacy benefit managers (PBMs) and drug distributors for drug manufacturers’ ongoing refusal to meaningfully reduce drug prices. The senators’ letter follows new information obtained from PBMs and drug distributors that directly contradicts the allegations made by Secretary Azar and raises questions about the accuracy of his testimony to Congress. Despite President Trump’s promises that drug companies would voluntarily enact “massive” price cuts, there have been no significant drug price

U.S. Sens. Tina Smith, Amy Klobuchar Honor the Storied Life of Minnesota’s First Female Member of Congress, Coya Knutson, with Senate Resolution

MINNESOTA [08/22/18]—  Today, Minnesota’s U.S. Sens. Tina Smith and Amy Klobuchar honored the storied life of Minnesota’s first female member Congress, Coya Knutson, with a Senate Resolution heralding her life as a trailblazer who, despite great obstacles when she served in the 1950s, succeeded in making a difference for the families and communities in her state.  You can read a copy of the Resolution here. The resolution, offered Wednesday on what would have been Knutson’s 106th birthday, notes that after arriving in Washington, D.C in 1954, she convinced Speaker Sam Rayburn to appoint her to be the first woman ever to serve on the House

Klobuchar, Smith, Reed Call on Administration to Protect U.S. Troops and Families from Financial Fraud

WASHINGTON – U.S. Senators Amy Klobuchar and Tina Smith joined Senator Jack Reed (D-RI) and 46 other senators in calling on the Consumer Financial Protection Bureau (CFPB) to maintain financial protections for servicemembers and their families under the Military Lending Act (MLA). Recent reports have indicated that the Administration is planning to stop examining lenders for violations of the MLA. In their letter, the senators urged CFPB Acting Director Mick Mulvaney not to end its examinations of payday lenders and other financial institutions for MLA compliance, and to not undertake measures that risk leaving U.S. troops and their families vulnerable to exploitation.

U.S. Sen. Tina Smith Presses Swiss Pharmaceutical Giant Novartis to Ensure Improper Company Actions Aren’t Pushing Up U.S. Prescription Drug Prices

WASHINGTON D.C. [08/23/18]— Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts – including a $1.2 million dollar payment to President Trump’s former lawyer Michael Cohen – that could be contributing to high prescription drug prices for people in Minnesota and across the country. In May, Novartis confirmed that it erred when it paid Cohen through a shell company to help influence Trump Administration health care policy. Those payments came after Novartis had already agreed in 2016 to comply with a U.S. Securities and Exchange Commission (SEC) order to establish

en_USEnglish